These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 9748281

  • 1. Identification of the rat adapter Grb14 as an inhibitor of insulin actions.
    Kasus-Jacobi A, Perdereau D, Auzan C, Clauser E, Van Obberghen E, Mauvais-Jarvis F, Girard J, Burnol AF.
    J Biol Chem; 1998 Oct 02; 273(40):26026-35. PubMed ID: 9748281
    [Abstract] [Full Text] [Related]

  • 2. SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase.
    Kotani K, Wilden P, Pillay TS.
    Biochem J; 1998 Oct 01; 335 ( Pt 1)(Pt 1):103-9. PubMed ID: 9742218
    [Abstract] [Full Text] [Related]

  • 3. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.
    Ahmed Z, Pillay TS.
    Biochem J; 2003 Apr 15; 371(Pt 2):405-12. PubMed ID: 12521378
    [Abstract] [Full Text] [Related]

  • 4. PSM, an insulin-dependent, pro-rich, PH, SH2 domain containing partner of the insulin receptor.
    Riedel H, Wang J, Hansen H, Yousaf N.
    J Biochem; 1997 Dec 15; 122(6):1105-13. PubMed ID: 9498552
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor-I receptor and insulin receptor association with a Src homology-2 domain-containing putative adapter.
    Wang J, Riedel H.
    J Biol Chem; 1998 Feb 06; 273(6):3136-9. PubMed ID: 9452421
    [Abstract] [Full Text] [Related]

  • 6. Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2.
    Kasus-Jacobi A, Béréziat V, Perdereau D, Girard J, Burnol AF.
    Oncogene; 2000 Apr 13; 19(16):2052-9. PubMed ID: 10803466
    [Abstract] [Full Text] [Related]

  • 7. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains.
    He W, Rose DW, Olefsky JM, Gustafson TA.
    J Biol Chem; 1998 Mar 20; 273(12):6860-7. PubMed ID: 9506989
    [Abstract] [Full Text] [Related]

  • 8. The adapter protein ZIP binds Grb14 and regulates its inhibitory action on insulin signaling by recruiting protein kinase Czeta.
    Cariou B, Perdereau D, Cailliau K, Browaeys-Poly E, Béréziat V, Vasseur-Cognet M, Girard J, Burnol AF.
    Mol Cell Biol; 2002 Oct 20; 22(20):6959-70. PubMed ID: 12242277
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14.
    Béréziat V, Kasus-Jacobi A, Perdereau D, Cariou B, Girard J, Burnol AF.
    J Biol Chem; 2002 Feb 15; 277(7):4845-52. PubMed ID: 11726652
    [Abstract] [Full Text] [Related]

  • 10. Tyrosine phosphorylation of tub and its association with Src homology 2 domain-containing proteins implicate tub in intracellular signaling by insulin.
    Kapeller R, Moriarty A, Strauss A, Stubdal H, Theriault K, Siebert E, Chickering T, Morgenstern JP, Tartaglia LA, Lillie J.
    J Biol Chem; 1999 Aug 27; 274(35):24980-6. PubMed ID: 10455176
    [Abstract] [Full Text] [Related]

  • 11. Expression and function of IRS-1 in insulin signal transmission.
    Sun XJ, Miralpeix M, Myers MG, Glasheen EM, Backer JM, Kahn CR, White MF.
    J Biol Chem; 1992 Nov 05; 267(31):22662-72. PubMed ID: 1385403
    [Abstract] [Full Text] [Related]

  • 12. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP, Lambert QT, Der CJ.
    J Biol Chem; 1998 Aug 07; 273(32):20431-7. PubMed ID: 9685397
    [Abstract] [Full Text] [Related]

  • 13. Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin. Evidence that IRS-1 phosphorylation is not sufficient for normal insulin action.
    Krook A, Moller DE, Dib K, O'Rahilly S.
    J Biol Chem; 1996 Mar 22; 271(12):7134-40. PubMed ID: 8636149
    [Abstract] [Full Text] [Related]

  • 14. Human growth factor receptor bound 14 binds the activated insulin receptor and alters the insulin-stimulated tyrosine phosphorylation levels of multiple proteins.
    Hemming R, Agatep R, Badiani K, Wyant K, Arthur G, Gietz RD, Triggs-Raine B.
    Biochem Cell Biol; 2001 Mar 22; 79(1):21-32. PubMed ID: 11235915
    [Abstract] [Full Text] [Related]

  • 15. The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains.
    Myers MG, White MF.
    Diabetes; 1993 May 22; 42(5):643-50. PubMed ID: 8387037
    [Abstract] [Full Text] [Related]

  • 16. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85.
    Myers MG, Backer JM, Sun XJ, Shoelson S, Hu P, Schlessinger J, Yoakim M, Schaffhausen B, White MF.
    Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10350-4. PubMed ID: 1332046
    [Abstract] [Full Text] [Related]

  • 17. Lipid-protein interactions of growth factor receptor-bound protein 14 in insulin receptor signaling.
    Rajala RV, Chan MD, Rajala A.
    Biochemistry; 2005 Nov 29; 44(47):15461-71. PubMed ID: 16300394
    [Abstract] [Full Text] [Related]

  • 18. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling.
    Goalstone ML, Leitner JW, Berhanu P, Sharma PM, Olefsky JM, Draznin B.
    J Biol Chem; 2001 Apr 20; 276(16):12805-12. PubMed ID: 11278505
    [Abstract] [Full Text] [Related]

  • 19. Site-directed mutagenesis and yeast two-hybrid studies of the insulin and insulin-like growth factor-1 receptors: the Src homology-2 domain-containing protein hGrb10 binds to the autophosphorylated tyrosine residues in the kinase domain of the insulin receptor.
    Dong LQ, Farris S, Christal J, Liu F.
    Mol Endocrinol; 1997 Nov 20; 11(12):1757-65. PubMed ID: 9369444
    [Abstract] [Full Text] [Related]

  • 20. Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphoinositide 3-kinase activation alone is not sufficient for the mediation of insulin's metabolic and mitogenic effects.
    Krook A, Whitehead JP, Dobson SP, Griffiths MR, Ouwens M, Baker C, Hayward AC, Sen SK, Maassen JA, Siddle K, Tavaré JM, O'Rahilly S.
    J Biol Chem; 1997 Nov 28; 272(48):30208-14. PubMed ID: 9374504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.